Author

C. Paiboonrungruang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

B. Bowman· 1 shared B. Weissman· 1 shared C. Huang· 1 shared D. Lamson· 1 shared E. W. Livingston· 1 shared H. Yuan· 1 shared J. Chembo· 1 shared J. E. Frank· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Bowman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyRedox BiologyPeer-reviewedNov 1, 2023

Small Molecule Screen Identifies Pyrimethamine as an Inhibitor of NRF2-driven Esophageal Hyperplasia

C. Paiboonrungruang, Z. Xiong, D. Lamson…·X. Chen

This study identifies pyrimethamine as an NRF2 inhibitor that suppresses esophageal hyperplasia in a mouse model and shows potential for clinical use in NRF2-high ESCC.

DOI 10.1016/j.redox.2023.102901

mousebulk RNA-seq

𝕏 PostBluesky